AU2002315631A1 - Pharmaceutical preparation comprising physiologically acceptable potassium and magnesium salts and use thereof for the prophylaxis and treatment of qt-interval extension - Google Patents

Pharmaceutical preparation comprising physiologically acceptable potassium and magnesium salts and use thereof for the prophylaxis and treatment of qt-interval extension

Info

Publication number
AU2002315631A1
AU2002315631A1 AU2002315631A AU2002315631A AU2002315631A1 AU 2002315631 A1 AU2002315631 A1 AU 2002315631A1 AU 2002315631 A AU2002315631 A AU 2002315631A AU 2002315631 A AU2002315631 A AU 2002315631A AU 2002315631 A1 AU2002315631 A1 AU 2002315631A1
Authority
AU
Australia
Prior art keywords
prophylaxis
treatment
physiologically acceptable
pharmaceutical preparation
magnesium salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002315631A
Inventor
Rudy Susilo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trommsdorff GmbH and Co KG
Original Assignee
Trommsdorff GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trommsdorff GmbH and Co KG filed Critical Trommsdorff GmbH and Co KG
Publication of AU2002315631A1 publication Critical patent/AU2002315631A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002315631A 2001-05-22 2002-03-25 Pharmaceutical preparation comprising physiologically acceptable potassium and magnesium salts and use thereof for the prophylaxis and treatment of qt-interval extension Abandoned AU2002315631A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10126405A DE10126405A1 (en) 2001-05-22 2001-05-22 Pharmaceutical preparation containing physiologically compatible potassium and magnesium salts and its use for the prophylaxis and / or therapy of QT prolongations
DE10126405.4 2001-05-22
PCT/DE2002/001160 WO2002094377A2 (en) 2001-05-22 2002-03-25 Pharmaceutical preparation comprising physiologically acceptable potassium and magnesium salts and use thereof for the prophylaxis and treatment of qt-interval extension

Publications (1)

Publication Number Publication Date
AU2002315631A1 true AU2002315631A1 (en) 2002-12-03

Family

ID=7686682

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002315631A Abandoned AU2002315631A1 (en) 2001-05-22 2002-03-25 Pharmaceutical preparation comprising physiologically acceptable potassium and magnesium salts and use thereof for the prophylaxis and treatment of qt-interval extension

Country Status (3)

Country Link
AU (1) AU2002315631A1 (en)
DE (2) DE10126405A1 (en)
WO (1) WO2002094377A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1522322A1 (en) * 2003-10-10 2005-04-13 Witte, Frank, Dr. Cartilage regeneration
US20070249052A1 (en) * 2003-10-10 2007-10-25 Kw2 Implantattechnologie Gmbh Cartilage Regeneration By Generation Of Chondrons Under High Concentrations Of Magnesium

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582705A (en) * 1982-07-12 1986-04-15 Leonard Primes Composition for detoxification
CH677612A5 (en) * 1987-09-11 1991-06-14 Ciba Geigy Ag
GB9020091D0 (en) * 1990-09-14 1990-10-24 Nycomed As Contrast media
HU207800B (en) * 1990-05-10 1993-06-28 Andras Sikter Process for producing composition for improving condition and for treating different illnesses
DE4117904A1 (en) * 1991-05-31 1992-12-03 Basf Ag SUBSTITUTED N-PHENYLPIPERIDINES
ATE218854T1 (en) * 1997-01-31 2002-06-15 Univ Leland Stanford Junior TREATMENT OF CARDIAC ARTHRY DISORDERS BY INHIBITING A MULTIFUNCTIONAL CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE

Also Published As

Publication number Publication date
DE10292147D2 (en) 2004-04-29
WO2002094377A3 (en) 2003-05-08
DE10126405A1 (en) 2003-02-27
WO2002094377A2 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2002246152A1 (en) Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases
IL171726A (en) Quinoline derivatives , their use in the manufacture of medicaments for the prophylaxis or treatment of a clinical condition for which a selective pde4 inhibitor is indicated, their preparation and pharmaceutical compositions comprising them
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
IL162765A (en) Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use
AU2003254157A1 (en) Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease
HUP0400200A3 (en) Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof
AU2001269314A1 (en) Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
HK1068793A1 (en) Novel use of 2-Ä5-(4-fluorophenyl)-3-pyridylmethylaminomethylÜ and its physiologically acceptable salts
AU2003249105A1 (en) Processes for the preparation of oral dosage formulations of modafinil
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003236156A1 (en) Pharmaceutical compositions used for immune disease treatment and improvement
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
AU2002315631A1 (en) Pharmaceutical preparation comprising physiologically acceptable potassium and magnesium salts and use thereof for the prophylaxis and treatment of qt-interval extension
AU2003264954A1 (en) Pharmaceutical composition for prevention and treatment of kidney diseases
AU2003247001A1 (en) Processes for the preparation of oral dosage formulations of modafinil
AU2002328571A1 (en) Traditional chinese pharmaceutical formulation for treatment of paradentosis, process for preparation and use thereof
AU2002311141A1 (en) The use of hydrochloric acid in the preparation of a medicament for the treatment of tumour
AU2001262520A1 (en) Combined preparation for the treatment of neoplasic diseases
AU2002224253A1 (en) Medicine based on diethylaminoethanol derivatives and its use for the prevention and treatment of inflammatory and degenerative diseases
AU2003245674A1 (en) Oral disease prevention and treatment
AUPR637001A0 (en) Pharmaceutical composition for the treatment of skin conditions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase